Medications

Gilead's $2,340 price for coronavirus drug draws criticism

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other ...

Cardiology

Every heart dances to a different tune

Play the same piece of music to two people, and their hearts can respond very differently. That's the conclusion of a novel study presented today on EHRA Essentials 4 You, a scientific platform of the European Society of ...

Diseases, Conditions, Syndromes

With quirks and restrictions, many states lift lockdowns

More than a dozen states let restaurants, stores or other businesses reopen Friday in the biggest one-day push yet to get their economies up and running again, acting at their own speed and with their own quirks and restrictions ...

Diseases, Conditions, Syndromes

A coronavirus drug seems to work. What's next?

News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest – and a clamor to know how soon it might be available.

Medications

Hydroxychloroquine can shorten time to recovery in COVID-19: study

(HealthDay)—Hydroxychloroquine (HCQ) can shorten time to clinical recovery and promote pneumonia absorption among patients with coronavirus disease 2019 (COVID-19), according to a study that has not yet been peer reviewed ...

page 1 from 7